121800 Advanced Glycation Endproduct-BSA

121800
Nie udało się pobrać ceny
Minimum Quantity needs to be mulitiple of
Na zapytanie Więcej informacji
Zapisano ()
 
Poproś o podanie ceny netto
Niedostępny w magazynie PLNiedostępny w magazynie PL
Dostępny w magazynie 
Wycofano
Dostępna ograniczona ilość
Dostępność będzie potwierdzona
    Remaining : Will advise
      Remaining : Will advise
      Doradzimy
      Skontaktuj się z Zespołem Obsługi Klienta
      Contact Customer Service
      Wyświetl ceny i dostępność
      Kliknij, aby wydrukować tę stronę

      Przegląd

      Replacement Information

      Ceny i dostępność

      Numer katalogowyDostępność Opakowanie Ilość/opak. Cena netto Ilość
      121800-10MG
      Pobieram informacje o dostępności...
      Niedostępny w magazynie PLNiedostępny w magazynie PL
      Dostępny w magazynie 
      Wycofano
      Dostępna ograniczona ilość
      Dostępność będzie potwierdzona
        Remaining : Will advise
          Remaining : Will advise
          Doradzimy
          Skontaktuj się z Zespołem Obsługi Klienta
          Contact Customer Service

          Butelka szklana 10 mg
          Pobieranie ceny...
          Nie udało się pobrać ceny
          Minimum Quantity needs to be mulitiple of
          Na zapytanie Więcej informacji
          Zapisano ()
           
          Poproś o podanie ceny netto
          Description
          OverviewPrepared by reacting BSA with glycoaldehyde under sterile conditions. Glycated-BSA shows a 5,000 - 10,000% increase in fluorescence as compared to normal BSA (confirmed by fluorescence spectrophotometry, excitation/emission 370/440 nm). AGE-BSA has been reported to induce apoptosis in cultured human umbilical vein endothelial cells and inhibit nitric oxide synthase activity in proximal tubular epithelial cells. Advanced glycation end products and their receptors have been implicated in the pathogenesis of diabetes, induction of proinflammatory cytokines, and stimulation of smooth muscle proliferation, and fibronectin production.
          Catalogue Number121800
          Brand Family Calbiochem®
          SynonymsAGE-BSA
          References
          ReferencesOkamoto, T., et al. 2002. Microvasc. Res. 63, 186.
          Ohgami, N., et al. 2001. J. Biol. Chem. 276, 3195.
          Wang, R., et al. 2001. J. Nippon Med. Sch. 68, 472.
          Sakata, N., et al. 2000. J. Atheroscler. Thromb. 7, 169.
          Verbeke, P., et al. 2000. Biochim. Biophys. Acta 1502, 481.
          Farboud, B., et al. 1999. Mol. Vis. 5, 11.
          Huang, J.-S., et al. 1999. Biochem. J. 342, 231.
          Min, C., et al. 1999. Diabetes Res. Clin. Pract. 46, 197.
          Neumann, A., et al. 1999. FEBS Lett. 453, 283.
          Stitt, A.W., et al. 1999. Biochem. Biophys. Res. Commun. 256, 549.
          Nazaimoon, W. and Bak, K. 1998. Malays. J. Pathol. 20, 83.
          Product Information
          FormLiquid
          FormulationIn sterile-filtered PBS.
          Applications
          Biological Information
          Purity≥95% by SDS-PAGE
          Concentration Label Please refer to vial label for lot-specific concentration
          Physicochemical Information
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Dry Ice Only
          Toxicity Standard Handling
          Storage ≤ -70°C
          Avoid freeze/thaw Avoid freeze/thaw
          Do not freeze Ok to freeze
          Special InstructionsFollowing initial thaw, aliquot and freeze (-70°C).
          Packaging Information
          Transport Information
          Supplemental Information
          Specifications

          Documentation

          MSDS

          Title

          Safety Data Sheet (SDS) 

          Certificates of Analysis

          TitleLot Number
          121800

          References

          Przegląd literatury
          Okamoto, T., et al. 2002. Microvasc. Res. 63, 186.
          Ohgami, N., et al. 2001. J. Biol. Chem. 276, 3195.
          Wang, R., et al. 2001. J. Nippon Med. Sch. 68, 472.
          Sakata, N., et al. 2000. J. Atheroscler. Thromb. 7, 169.
          Verbeke, P., et al. 2000. Biochim. Biophys. Acta 1502, 481.
          Farboud, B., et al. 1999. Mol. Vis. 5, 11.
          Huang, J.-S., et al. 1999. Biochem. J. 342, 231.
          Min, C., et al. 1999. Diabetes Res. Clin. Pract. 46, 197.
          Neumann, A., et al. 1999. FEBS Lett. 453, 283.
          Stitt, A.W., et al. 1999. Biochem. Biophys. Res. Commun. 256, 549.
          Nazaimoon, W. and Bak, K. 1998. Malays. J. Pathol. 20, 83.

          Brochure

          Title
          Caspases and other Apoptosis Related Tools Brochure
          Pathways and Biomarkers of Oxidative Stress
          Data Sheet

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision08-April-2008 RFH
          SynonymsAGE-BSA
          DescriptionPrepared by reacting bovine serum albumin (BSA) with glycoaldehyde under sterile conditions. Fluorescence of AGE-BSA is confirmed by fluorescence spectrophotometry, excitation/emission = 370/440 nm. Glycated BSA shows a 5000-10,000% increase in fluorescence compared to control BSA. AGE and their receptors have been implicated in the pathogenesis of diabetes, induction of pro-inflammatory cytokines, and stimulation of smooth muscle proliferation and fibronectin production. AGE-BSA has also been shown to induce apoptosis in cultured human umbilical vein endothelial cells (HUVEC) and inhibit nitric oxide synthase activity in proximal tubular epithelial cells of the kidney.
          FormLiquid
          FormulationIn sterile-filtered PBS.
          Concentration Label Please refer to vial label for lot-specific concentration
          Purity≥95% by SDS-PAGE
          Storage ≤ -70°C
          Avoid freeze/thaw
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing initial thaw, aliquot and freeze (-70°C).
          Toxicity Standard Handling
          ReferencesOkamoto, T., et al. 2002. Microvasc. Res. 63, 186.
          Ohgami, N., et al. 2001. J. Biol. Chem. 276, 3195.
          Wang, R., et al. 2001. J. Nippon Med. Sch. 68, 472.
          Sakata, N., et al. 2000. J. Atheroscler. Thromb. 7, 169.
          Verbeke, P., et al. 2000. Biochim. Biophys. Acta 1502, 481.
          Farboud, B., et al. 1999. Mol. Vis. 5, 11.
          Huang, J.-S., et al. 1999. Biochem. J. 342, 231.
          Min, C., et al. 1999. Diabetes Res. Clin. Pract. 46, 197.
          Neumann, A., et al. 1999. FEBS Lett. 453, 283.
          Stitt, A.W., et al. 1999. Biochem. Biophys. Res. Commun. 256, 549.
          Nazaimoon, W. and Bak, K. 1998. Malays. J. Pathol. 20, 83.